- Home
- NIKI vs ASBP Comparison
NIKI vs ASBP Comparison
Compare NIKI & ASBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$7.82
N/A
Current Price
$7.67
Company Overview
Basic Information| Metric | NIKI | ASBP |
|---|---|---|
| Founded | N/A | 2021 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8M | 6.8M |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | NIKI | ASBP |
|---|---|---|
| Price | $7.82 | $7.67 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 24.2K | ★ 37.3K |
| Earning Date | N/A | 04-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.80 | $0.05 |
| 52 Week High | $10.39 | $8.17 |
Technical Indicators
Market Signals| Indicator | NIKI | ASBP |
|---|---|---|
| Relative Strength Index (RSI) | 43.65 | 58.00 |
| Support Level | N/A | $4.44 |
| Resistance Level | $10.00 | $8.11 |
| Average True Range (ATR) | 0.83 | 0.59 |
| MACD | -0.17 | 0.02 |
| Stochastic Oscillator | 4.27 | 85.55 |
Price Performance
Historical Comparison NIKI
ASBP
About ASBP Aspire Biopharma Holdings Inc.
Aspire Biopharma Holdings Inc is an early-stage biopharmaceutical company focused on developing and commercializing novel sublingual drug delivery technologies. The company is mainly engaged in advancing patent-pending formulations designed to enable rapid absorption of drugs, initially targeting high-dose aspirin products for cardiovascular and pain management applications. Its technology aims to improve efficacy and response time by bypassing the gastrointestinal tract through sublingual delivery.